GRAL logo

GRAIL, Inc. (GRAL)

Profile

Full Name

GRAIL, Inc.

Ticker

NASDAQ: GRAL

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

June 12, 2024

Indexes

Not included

Website

https://grail.com

Employees

1000

Key Details

Price

$38.04(-1.58%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$125.59M(+34.90% YoY)

Annual EPS

-$63.54(-100.00% YoY)

PE ratio

-

Next earnings date

Nov 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $38.04
    GRAL price is $38.04

    30-Day Relative Volume

    0.64
    GRAL 30-day relative volume is 0.64

    Price Performance

    Price Most recent change

    -1.58%
    GRAL price was down -1.58% on Sep 12, 2025

    Price YTD change

    +113.11%
    GRAL price is up +113.11% since January 1st

    Price 1-year change

    +180.74%
    GRAL price is up +180.74% year-on-year

    Price 3-year change

    -
    GRAL price 3-year change is unknown

    Price Range

    Price All-time high

    $63.99
    GRAL price is currently -40.55% below its historical high of $63.99

    Price 3-year low

    $12.33
    GRAL price is currently +208.52% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.37B
    GRAL market capitalization is $1.37 billion

    Market cap 3-year change

    -
    GRAL market capitalization 3-year change is unknown

    Market cap All-time high

    $1.86B
    GRAL market capitalization is currently -26.47% below its historical high of $1.86 billion

    Market cap sector rank

    76.53%
    GRAL market capitalization is higher than 76.53% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +16.1%
    GRAL shares outstanding is up +16.1% year-on-year

    Shares Outstanding 3-Year Change

    -75.27%
    GRAL shares outstanding is down -75.27% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    2.31
    GRAL beta is 2.31

    200-day SMA

    $32.50
    GRAL price is currently +17.05% above its 200-day simple moving average

    50-day SMA

    $35.94
    GRAL price is currently +5.84% above its 50-day simple moving average

    RSI

    58.05
    GRAL 14-day relative strength index is 58.05

    Volume

    0.64
    GRAL 30-day relative volume is 0.64

    ATR

    $2.27
    GRAL average true range is $2.27

    10-day Historical Volatility

    85.90%
    GRAL 10-day historical volatility is 85.90%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $125.59M
    GRAL annual revenue is $125.59 million

    Revenue Analysts estimate

    $143.47M
    GRAL annual revenue is currently -12.46% lower than the consensus analysts' forecast

    Revenue 1-year change

    +34.9%
    GRAL annual revenue is up +34.9% year-on-year

    Revenue Sector rank

    69.83%
    GRAL annual revenue is higher than 69.83% of companies in Healthcare sector

    EPS

    EPS

    -$63.54
    GRAL annual earnings per share is -$63.54

    EPS Analysts estimate

    -$11.55
    GRAL annual earnings per share is currently +450.13% higher than the consensus analysts' forecast

    EPS 1-year change

    -100%
    GRAL annual earnings per share is down -100% year-on-year

    EPS Sector rank

    3.96%
    GRAL annual earnings per share is higher than 3.96% of companies in Healthcare sector

    Profit

    Gross profit

    -$78.02M
    GRAL annual gross profit is -$78.02 million

    Gross margin

    -62.12%
    GRAL annual gross profit margin is -62.12%

    Operating profit

    -$727.75M
    GRAL annual operating income is -$727.75 million

    Operating margin

    -579.44%
    GRAL annual operating profit margin is -579.44%

    Net income

    -$2.03B
    GRAL annual net profit is -$2.03 billion

    Net margin

    -1613.92%
    GRAL annual net profit margin is -1613.92%

    Expenses

    Total expenses

    $2.15B
    GRAL annual total expenses is $2.15 billion

    Operating expenses

    $649.73M
    GRAL annual total operating expenses is $649.73 million

    Cost of goods sold

    $203.62M
    GRAL annual cost of goods sold is $203.62 million

    Selling, general & administrative expenses

    $0.00
    GRAL annual SGA is $0.00

    Depreciation and amortization

    $158.06M
    GRAL annual depreciation & amortization is $158.06 million

    Interest expense

    $0.00
    GRAL annual interest expense is $0.00

    Income tax

    -$135.36M
    GRAL annual income tax is -$135.36 million

    EBIT & EBITDA

    EBIT

    -$727.75M
    GRAL annual earnings before interest & taxes is -$727.75 million

    EBITDA

    -$569.70M
    GRAL annual EBITDA is -$569.70 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $3.14B
    GRAL annual total assets is $3.14 billion

    Non current assets

    $2.16B
    GRAL annual long term assets is $2.16 billion

    Current assets

    $819.86M
    GRAL annual total current assets is $819.86 million

    Cash and cash equivalents

    $763.47M
    GRAL annual cash & cash equivalents is $763.47 million

    Accounts receivable

    $20.31M
    GRAL annual accounts receivable is $20.31 million

    Inventory

    $18.63M
    GRAL annual inventory is $18.63 million

    Liabilities

    Total liabilities

    $638.99M
    GRAL annual total liabilities is $638.99 million

    Long term liabilities

    $507.19M
    GRAL annual total long term liabilities is $507.19 million

    Current liabilities

    $76.92M
    GRAL annual total current liabilities is $76.92 million

    Accounts payable

    $4.84M
    GRAL annual accounts payable is $4.84 million

    Debt

    Total debt

    $68.14M
    GRAL annual total debt is $68.14 million

    Total debt 1-year change

    -19.27%
    GRAL annual total debt is down -19.27% year-on-year

    Long term debt

    $54.88M
    GRAL annual long term debt is $54.88 million

    Short term debt

    $13.26M
    GRAL annual short term debt is $13.26 million

    Equity & Capital

    Shareholders equity

    $2.50B
    GRAL annual stockholders equity is $2.50 billion

    Book value

    $2.50B
    GRAL annual book value is $2.50 billion

    Retained earnings

    -$9.80B
    GRAL annual retained earnings is -$9.80 billion

    Working capital

    $742.94M
    GRAL annual working capital is $742.94 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$577.16M
    GRAL annual cash flow from operations is -$577.16 million

    Cash from operations 1-year change

    +3.13%
    GRAL annual cash flow from operations is up +3.13% year-on-year

    Cash from investing

    -$551.01M
    GRAL annual cash flow from investing activities is -$551.01 million

    Cash from investing 1-year change

    -4175.71%
    GRAL annual cash flow from investing activities is down -4175.71% year-on-year

    Cash from financing

    $1.24B
    GRAL annual cash flow from financing activities is $1.24 billion

    Cash from financing 1-year change

    +168.3%
    GRAL annual cash flow from financing activities is up +168.3% year-on-year

    CAPEX

    CAPEX

    $5.21M
    GRAL annual capital expenditures is $5.21 million

    CAPEX 1-year change

    -59.59%
    GRAL annual capital expenditures is down -59.59% year-on-year

    Free Cash Flow

    Free cash flow

    -$582.36M
    GRAL annual free cash flow is -$582.36 million

    Free cash flow 1-year change

    +4.32%
    GRAL annual free cash flow is up +4.32% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -62.12%
    GRAL annual gross profit margin is -62.12%

    Operating margin

    -579.44%
    GRAL annual operating profit margin is -579.44%

    Net margin

    -1613.92%
    GRAL annual net profit margin is -1613.92%

    ROA & ROE

    ROA

    -52.65%
    GRAL annual return on assets is -52.65%

    ROE

    -65.92%
    GRAL annual return on equity is -65.92%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    GRAL price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    GRAL price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.59
    GRAL price to book ratio is 0.59

    PB ratio Sector rank

    25.97%
    GRAL price to book ratio is higher than 25.97% of companies in Healthcare sector

    PS Ratio

    PS ratio

    10.21
    GRAL price to sales ratio is 10.21

    PS ratio Sector rank

    73.48%
    GRAL price to sales ratio is higher than 73.48% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $830.67M
    GRAL enterprise value is $830.67 million

    Enterprise value Sector rank

    71.49%
    GRAL enterprise value is higher than 71.49% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.93
    GRAL EV/EBITDA is -1.93

    EV/EBITDA Sector rank

    37.42%
    GRAL EV/EBITDA is higher than 37.42% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.66
    GRAL annual current ratio is 10.66

    Quick ratio

    10.42
    GRAL annual quick ratio is 10.42

    Leverage

    Debt to equity

    0.03
    GRAL annual debt to equity ratio is 0.03

    Interest coverage ratio

    -
    GRAL annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    GRAL piotroski f-score is 3

    Altman Z-Score

    -3.52
    GRAL altman z-score is -3.52

    Analyst ratings

    Recent major analysts updates

    May 14, 25 Canaccord Genuity
    Buy
    Apr 21, 25 Canaccord Genuity
    Buy
    Mar 18, 25 Morgan Stanley
    Equal-Weight
    Nov 27, 24 Morgan Stanley
    Equal-Weight
    Oct 17, 24 Guggenheim
    Neutral

    Institutional Ownership

    Screeners with GRAL included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for GRAIL, Inc.?
    • Does GRAIL, Inc. pay dividends?
    • What sector is GRAIL, Inc. in?
    • What industry is GRAIL, Inc. in?
    • What country is GRAIL, Inc. based in?
    • When did GRAIL, Inc. go public?
    • Is GRAIL, Inc. in the S&P 500?
    • Is GRAIL, Inc. in the NASDAQ 100?
    • Is GRAIL, Inc. in the Dow Jones?
    • When was GRAIL, Inc.'s last earnings report?
    • When does GRAIL, Inc. report earnings?

    What is the ticker symbol for GRAIL, Inc.?

    The ticker symbol for GRAIL, Inc. is NASDAQ:GRAL

    Does GRAIL, Inc. pay dividends?

    No, GRAIL, Inc. does not pay dividends

    What sector is GRAIL, Inc. in?

    GRAIL, Inc. is in the Healthcare sector

    What industry is GRAIL, Inc. in?

    GRAIL, Inc. is in the Diagnostics & Research industry

    What country is GRAIL, Inc. based in?

    GRAIL, Inc. is headquartered in United States

    When did GRAIL, Inc. go public?

    GRAIL, Inc.'s initial public offering (IPO) was on June 12, 2024

    Is GRAIL, Inc. in the S&P 500?

    No, GRAIL, Inc. is not included in the S&P 500 index

    Is GRAIL, Inc. in the NASDAQ 100?

    No, GRAIL, Inc. is not included in the NASDAQ 100 index

    Is GRAIL, Inc. in the Dow Jones?

    No, GRAIL, Inc. is not included in the Dow Jones index

    When was GRAIL, Inc.'s last earnings report?

    GRAIL, Inc.'s most recent earnings report was on August 12, 2025

    When does GRAIL, Inc. report earnings?

    The next expected earnings date for GRAIL, Inc. is November 11, 2025
    On this page